The expression of LMO 2 protein in acute B-cell and myeloid leukemia

Hematology

Volumn 15, Issue 3, 2010, Pages 132-134

  Cobanoglu, Umit ^a   Sonmez, Mehmet ^a   Ozbas, Hasan Mucahit ^a   Erkut, Nergis ^a   Can, Gamze ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Acute leukemia; LMO 2 protein

Indexed keywords

LIM DOMAIN ONLY 2; PARAFFIN; PROTEIN; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; LMO2 PROTEIN, HUMAN; METALLOPROTEIN; ONCOPROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGED; ARTICLE; B CELL LEUKEMIA; BONE MARROW BIOPSY; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADOLESCENT; BIOSYNTHESIS; CELL DIFFERENTIATION; FEMALE; GENE EXPRESSION REGULATION; GENETICS; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADOLESCENT; ADULT; AGED; CELL DIFFERENTIATION; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, LEUKEMIC; HUMANS; LEUKEMIA, B-CELL; LEUKEMIA, MYELOID, ACUTE; MALE; METALLOPROTEINS; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; YOUNG ADULT;

EID: 77953563721     PISSN: 10245332     EISSN: 16078454     Source Type: Journal    
DOI: 10.1179/102453309X12583347113618     Document Type: Article

References (13)

1. Warren AJ, Colledge WH, Carlton MB, Evans MJ, Smith AJ, Rabbitts TH. The oncogenic cysteine-rich LIM domain protein rbtn2 is essential for erythroid development. Cell 1994; 78: 45-57.
2. Yamada Y, Pannell R, Forster A, Rabbitts TH. The oncogenic LIM-only transcription factor Lmo2 regulates angiogenesis but not vasculogenesis in mice. Proc Natl Acad Sci USA 2000; 97: 320-324.
3. Royer-Pokora B, Loos U, Ludwig WD. TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11). Oncogene 1991; 6: 1887-1893.
4. Rabbitts TH. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev 1998; 12: 2651-2657.
5. Natkunam Y, Zhao S, Mason DY et al. The oncoprotein LMO2 is expressed in normal germinal-center B cells and in human B-cell lymphomas. Blood 2007; 109:1636-1642.
6. Dong WF, Bilia F,Atkins HL et al. Expression of rhombotin 2 in normal and leukaemic haemopoetic cells. Br J Haematol 1996; 93: 280-286.
7. Swirsky DM, Richards SJ, Evans PAS. Acute leukemias. In: Wickramasinghe SN, McCullough J. (eds) Blood and bone marrow pathology, 1th edn. London: Churchill Livingstone, 2003; 351-380.
8. Jaffe ES, Haris NL, Stein H, Vardiman JW (eds). Pathology and Genetics of Tumors of the Hematopoietic and Lymphoid Tissues. Lyon: International Agency for Research on Cancer Press, 2001; 77-117.
9. Bach I. The LIM domain: regulation by association. Mech Dev 2000; 91: 5-17.
10. Izraeli S. Leukemia - a developmental perspective. Br J Haematol 2004; 126: 3-10.
11. Natkunam Y, Farinha P, Hsi ED et al. LMO2 protein expression predicts survival in patients with diffuse large B-cell lymphoma treated with anthracycline-based chemotherapy with and without rituximab. J Clin Oncol 2008; 26: 447-454.
12. McCormack MP, Rabbitts TH. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency. N Engl J Med 2004; 350: 913-922.
13. Foroni L, Boehm T, White L et al. The rhombotin gene family encodes related LIM-domain proteins whose differing expression suggests multiple roles in mouse development. J Mol Biol 1992; 226: 747-761.